Cardiac Resynchronization Therapy Devices Exhibits a Boost

Despite contributing 34% share in the cardiac rhythm management sector, the cardiac resynchronization therapy devices are expected to drive the segment in future, says RNCOS.

Noida, India (prHWY.com) September 4, 2012 - As per the new research report by RNCOS "US Cardiac Device Market Analysis", the US has been witnessing an uprise in the incidences of cardiovascular-related complications and therefore the cardiac medical devices sector is a current industry focus. As the population is getting older, this trend is expected to continue in future also, thereby supporting the prominent growth in the sector. With the total size hovering around US$ 17.5 Billion in 2011, the market is further expected to perform good in coming years also with technological upgradation playing a key role.

We have found that cardiac resynchronization therapy devices is expected to fuel the growth in the US cardiac rhythm management market, which currently is dominated by implantable cardioverter defibrillator (ICD). High incidences of congestive heart failure will boost the cardiac resynchronization therapy sub-segment in future, which contributed around 34% in the 2011 cardiac rhythm management sector.

Our report covers all the key aspects of the US cardiac medical devices market and effectively analyzes its current status and expected position in the future. Moreover, it analyzes the current performance of industry segments (cardiac rhythm management, interventional cardiology and cardiovascular surgery) and the share of other sub-segments. It also elaborates the regulatory framework associated with cardiac devices and investigates the role of key authorities in it.

The report, which is an outcome of an extensive research and in-depth analysis, facilitates the future forecasts on overall US cardiac medical devices market size during 2012-2015. It analyzes the opportunity assessment for companies in the US cardiac medical devices market by providing prudent analysis of competitors' profiling that covers areas like business description, financial overview, strengths & weaknesses and key developments. Overall, the report is meant to provide clients with an optimum source of knowledge and statistics in the US cardiac medical devices sector.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM441.htm

Some of our Related Reports are:

- US Clinical Laboratory Testing Market Assessment
(http://www.rncos.com/Report/IM442.htm)
- Global Genetic Testing Market Forecast to 2015
(http://www.rncos.com/Report/IM445.htm)
- Indian Diagnostic Services Market Outlook 2015
(http://www.rncos.com/Report/IM418.htm)
- US Nutraceuticals Market Analysis (http://www.rncos.com/Report/IM350.htm)
- China Healthcare Market Forecast to 2015 (http://www.rncos.com/Report/IM409.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: us cardiac device market

Categories: Biotech

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code